Open Nav
Open Nav
Deep brain stimulation (DBS) of the subthalamic nucleus (STN) and globus pallidus internus (GPi) for Parkinson’s disease, and the ventral intermediate nucleus (VIM) for essential tremor, has demonstrated robust and durable clinical efficacy in managing motor symptoms in patients with Parkinson’s disease and essential tremor that remain inadequately controlled with pharmacological therapy.1–3Â
Recent technological innovations have fundamentally transformed DBS programming.4,6 Image Guided Programming (IGP) uses patient‑specific anatomical reconstructions from pre‑ and post‑operative imaging to support efficient DBS programming and improved clinical outcomes.4,5 Illumina 3D™, the latest advancement in IGP from Boston Scientific, generates a suggested stimulation field model (SFM) within seconds to provide an informed, anatomy‑based starting point clinicians can refine to individual patient needs.6
In this touchFEATURE, neurologist Jessica Feldman, MD, and neurosurgeon Casey Halpern, MD, discuss the clinical role of DBS in Parkinson’s disease and essential tremor, the need to broaden access to DBS within community neurology, and how advancements in DBS programming are facilitating collaboration across specialties to support patient care over time.
After watching this activity, participants should be better able to:
Jung IH, et al. Complications after deep brain stimulation: a 21-year experience in 426 patients. Front Aging Neurosci. 2022;14:819730.
Weaver FM, et al. Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. JAMA. 2009;301(1):63–73.
Wharen RE Jr, et al. Thalamic deep brain stimulation with a constant-current device in essential tremor: a controlled clinical trial. Parkinsonism Relat Disord. 2017;40:18–26.
Lange F, et al. Reduced programming time and strong symptom control even in chronic course through imaging-based DBS programming. Front Neurol. 2021;12:785529.
Torres V, et al. Image-guided programming deep brain stimulation improves clinical outcomes in patients with Parkinson’s disease. NPJ Parkinsons Dis. 2024;10:29.
Aldred J, et al. Automated image guided programming algorithm supports clinicians during DBS programming for PD patients. Poster presented at the International Parkinson and Movement Disorders Society (MDS) annual meeting, Honolulu, HI, USA, October 5–9, 2025.
Jessica Feldman, MD is a board-certified general neurologist at Penn Medicine based in Sellersville and Chalfont, Pennsylvania. Her clinical work spans general neurology, Parkinson’s disease, dementia, stroke care and neuropathy, with particular experience in electromyography, electroencephalography, lumbar puncture, and the use of botulinum toxin for neurological indications. Dr Feldman has held leadership positions such as Director of the Stroke Program at Grandview Hospital and Abington Lansdale Hospital and President and Vice President of the Bucks County Medical Society. In addition, she has held professional memberships with the American Academy in Neurology, American Medical Association, and Pennsylvania Medical Society. Dr Feldman is active in medical education as a frequent speaker to internal medicine physicians, neurologists and patients, and received the AB Baker American Academy of Neurology Teaching Award in 2024.
Provided consultancy or speaker services to AbbVie, Boston Scientific and EMD Serono Pharmaceuticals.
Neurosurgeon
Casey Halpern, MD is a Professor of Neurosurgery at the Perelman School of Medicine at the University of Pennsylvania and Division Head of Functional and Stereotactic Neurosurgery at Penn Medicine and Pennsylvania Hospital. His clinical practice focuses on stereotactic and functional procedures for movement disorders, including Parkinson’s disease, essential tremor, severe dystonia, and Tourette syndrome, as well as epilepsy and certain psychiatric conditions. He is particularly known for using deep brain stimulation (DBS) and focused ultrasound to treat these disorders and has a research interest in developing clinical trials to expand indications for DBS and other novel brain surgical therapies. Casey Halpern, MD was honored with the NIH Director’s Pioneer Award in 2025.
Provided consultancy services to Abbott, Boston Scientific, Insightec, and Medtronic. Holds the position of Chairman for SynchNeuro, Inc. and LeoNeuro, Inc., and has patents related (not licensed) and unrelated (licensed) to this work, owned by Standford University, the University of Pennsylvania, SynchNeuro, Inc. and LeoNeuro, Inc.
View and download resources from this activity to support your learning and share with colleagues
This activity is sponsored by Boston Scientific.
Boston Scientific provided financial support and video content, and has had input into the detailed project scope. Video content is © 2026 Boston Scientific Corporation or its affiliates. All rights reserved. This activity is provided by touchMEDICAL for touchNEUROLOGY.
We were unable to verify your IP address, please try again later. If you are using a method to hide your IP address, such as a VPN or proxy, please disable this and try again.
Boston Scientific provided financial support and video content, and has had input into the detailed project scope. This activity is provided by touchMEDICAL for touchNEUROLOGY.
Dr. Feldman and Dr. Halpern were compensated for their time in the creation of this activity.
All trademarks are the property of their respective owners
View Boston Scientific Deep Brain System Indications, Safety, and Warnings at bostonscientific.com/dbs-indications.
Unapproved products or unapproved uses of approved products may be discussed; these situations may reflect the approval status in one or more jurisdictions. touchMEDICAL has advised the sponsor to ensure that they disclose any such references made to unlabelled or unapproved use. No endorsement by touchMEDICAL of any unapproved products or unapproved uses is either made or implied by mention of these products or uses in touchMEDICAL activities. touchMEDICAL accepts no responsibility for errors or omissions.
The views and opinions expressed are those of the faculty and do not necessarily reflect those of any sponsor.
NM-2426304-AB
Video content is © 2026 Boston Scientific Corporation or its affiliates. All rights reserved.
Date of preparation: August 2026
Keep track of your clinical interests and newsletter subscriptions.
Register for free to hear about the latest expert-led education, peer-reviewed articles, conference highlights, and innovative CME activities.
Or use a Social Account.
Already registered? Login below.